Article
Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter
2020-08-25
Abstract excerpt
Safe access to the most effective treatment options for Plasmodium vivax malaria are limited by the absence of accurate point-of-care testing to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency, the most common human genetic disorder. G6PD-deficient patients are at risk of life-threatening hemolysis when exposed to 8-aminoquinolines, the only class of drugs efficacious against P. vivax hypnozoites. U...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4247340-9563-5761-af44-cedbe2bb21b2
- DOI
- 10.12688/wellcomeopenres.15700.2
